Scilex Holding Company Warrant financials
$0.0880+40.35%
Close Sep 25, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $30.3M | $56.6M | $46.7M | $38.0M |
| Gross profit | $19.7M | $39.9M | $31.1M | $27.2M |
| Gross margin | 65.0% | 70.5% | 66.5% | 71.6% |
| Operating income | -$346.0M | -$83.4M | -$105.4M | -$50.6M |
| Net income | -$402.5M | -$72.8M | -$167.0M | -$23.4M |
| Net margin | −1330.4% | −128.7% | −357.2% | −61.4% |
| Diluted EPS | $-36.48 | $-8.05 | $-44.80 | $-5.95 |
| EBITDA | -$267.7M | -$88.7M | -$101.3M | -$46.7M |
| Operating cash flow | $3.8M | $19.3M | -$20.7M | -$21.3M |
| Free cash flow | $3.7M | $19.3M | -$20.7M | -$21.3M |
| Diluted shares | 11.0M | 10.1M | 3.7M | 3.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $5.0M | $3.3M | $3.9M | $2.2M |
| Short-term investments | $6.0M | $0.00 | $0.00 | $0.00 |
| Total debt | $109.3M | $35.7M | $125.5M | $0.00 |
| Total assets | $365.0M | $93.0M | $101.3M | $86.5M |
| Total liabilities | $576.7M | $285.6M | $274.2M | $50.3M |
| Shareholders' equity | -$211.8M | -$192.6M | -$172.9M | $36.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology